Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Agila Specialties Private Limited
WARNING LETTER
•Agila Specialties Private Limited•June 27, 2013

Agila Specialties Private Limited – FDA Warning Letter, Jun 27, 2013

Record Details

The FDA issued a Warning Letter to Agila Specialties Private Limited, Specialty Formulation Facility (SFF) in Bangalore, India, following a June 2013 inspection that revealed significant Current Good Manufacturing Practice (CGMP) violations (21 CFR Part 210 and 211), rendering their drug products adulterated. The firm's response was deemed insufficient. Key violations include failure to establish and follow procedures to prevent microbiological contamination of sterile products, such as using non-integral gloves and inadequate media fill studies (21 CFR 211.113(b)). Deficiencies were also noted in environmental monitoring systems (21 CFR 211.42(c)(10)(iv)), facility controls to prevent contamination (21 CFR 211.42(c)), and thorough investigation of discrepancies (21 CFR 211.192), which was a repeat observation. Further issues involved inadequate laboratory controls for stability testing (21 CFR 211.160(b)), lack of appropriate computer system controls for data integrity (21 CFR 211.68(b)), and failure to maintain buildings in a sanitary condition, including mold in cold storage (21 CFR 211.56(a)). These extensive deficiencies indicate a lack of effective quality management and understanding of microbial controls. The FDA requires comprehensive corrective actions, including revised procedures, new media fill data, and retrospective evaluations, with potential consequences including withholding new drug approvals and refusal of product admission into the U.S.

Company
Agila Specialties Private Limited
Inspection date
June 27, 2013
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Michael D. Smedley
View Company Profile

ID · 7a23e2b8-014e-4db4-b8bb-beafae7ac754

Violation Codes10
21 U.S.C. 351(a)(2)(B)21 CFR 21021 CFR 21121 CFR 211.113(b)21 CFR 211.42(c)(10)(iv)21 CFR 211.42(c)21 CFR 211.19221 CFR 211.160(b)21 CFR 211.68(b)21 CFR 211.56(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Agila Specialties Private Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.